Theradiag SA
PAR:ALTER
Theradiag SA
Goodwill
Theradiag SA
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Theradiag SA
PAR:ALTER
|
Goodwill
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Goodwill
€2.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Biomerieux SA
PAR:BIM
|
Goodwill
€727.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Goodwill
€8m
|
CAGR 3-Years
26%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Goodwill
€98.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Theradiag SA
Glance View
Theradiag SA engages in the distribution, development and manufacturing of in vitro diagnostic and theranostics tests. The company is headquartered in Croissy-Beaubourg, Ile-De-France. The company went IPO on 2012-12-11. The firm develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. TheraDiags product offering consists of tests using a range of techniques (Elisa, rapid tests, immunofluorescence, Dot, immunochemical tests, molecular biology, etc.) as well as a range of automatic devices and solutions for high-speed diagnostics based on Luminexs Multiplex technology. The company has also developed a range of theranostic diagnostics commercialized under the Lisa-Tracker brand which provide monitoring of patients treated by anti-TNF monoclonal antibodies. TheraDiag is active in more than 30 countries, as an independent distributor.
See Also
What is Theradiag SA's Goodwill?
Goodwill
0
EUR
Based on the financial report for Jun 30, 2023, Theradiag SA's Goodwill amounts to 0 EUR.
